TCTAP 2025 Sponsors

Sanofi-Aventis Korea

Logo
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi-aventis Korea has maintained its certification as Family Friendly Company since 2013 and its accreditation as Innovative Pharmaceutical Company since 2014. We are in Korea committed to working with local pharmaceutical companies, bio-techs, clinical research centers as well as academia in Korea to bring innovation where high unmet patient needs exist.

Exhibition Item

Plavix, Praluent

Satellite Symposium

Lunchtime Activities

Optimizing Cardiovascular Outcomes: Early LDL-C Reduction and Individualized Therapy

Organized by CVRF and Supported by Educational Grant From Sanofi Korea

Friday, April 25
12:45 PM ~ 1:45 PM * KST (UTC/GMT +9:00)
Room 202, Level 2
12:45 PM LDL-C Lowering: Why Earlier is Better & When to Act?
Lecturer: Choongki Kim
1:05 PM Personalized LDL-C Reduction: Maximizing Outcomes With Alirocumab 300mg
Lecturer: Eunkyu Lee
1:25 PM Discussion

Lunchtime Activities

Optimized Antiplatelet Strategy for Patients With Acute Coronary Syndrome: From the Acute Phase to the Long-Term Phase

Organized by CVRF and Supported by Educational Grant From Sanofi Korea

Saturday, April 26
12:45 PM ~ 1:45 PM * KST (UTC/GMT +9:00)
Presentation Room 2, Level 1
Moderator(s): Eun-Seok Shin, Jon Suh
12:45 PM Opening Remarks
12:50 PM Strategic Acute Phase ACS Management: Clopidogrel-Centric Approaches
Lecturer: Sanghoon Shin
1:10 PM Strategic Long-Term Use of Clopidogrel in Acute Coronary Syndrome
Lecturer: Si-Hyuck Kang
1:30 PM Discussion